Treatment Planning

December 20, 2016 — The U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for Siemens’ Somatom Confidence Radiation Therapy (RT) Pro computed tomography (CT) scanner with features dedicated to RT planning.

September 14, 2016 — P-Cure, provider of patient-centric solutions for proton therapy, has received U.S. Food and Drug Administration (FDA) approval for its patented upright imaging solution.

The American Society for Radiation Oncology (ASTRO) announced the press program for its 58th Annual Meeting, Sept. 25-28 in Boston. The program includes multiple reports from phase III clinical trials, researchers from leading institutions in the United States and abroad, and examinations of a...

RaySearch Laboratories AB announced that version 5 of the RayStation treatment planning system has been released for clinical use in the United Kingdom, Australia and New Zealand. The latest version of the platform is scheduled for release in most major markets during the first half of 2016.

As proton therapy becomes more widely available, imaging for the development of proton treatment plans will become more commonplace. However, there are major differences in how treatment is planned for proton therapy compared to traditional radiation therapy.